Murmansk Regional Clinical Hospital named after Bayandin

Murmansk 183047

0 studies enrolling now · 3 studies all time

What they study most

Crohn Disease, Dyslipidemia, First Line Non-Small Cell Lung Cancer, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity — Completed